Literature DB >> 26557819

Targeted Therapies in Breast Cancer: New Approaches and Old Challenges.

Isabell Witzel1, Volkmar Müller1.   

Abstract

Entities:  

Year:  2015        PMID： 26557819      PMCID： PMC4569251          DOI： 10.1159/000431067

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  7 in total

Review 1.  Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators.

Authors:  Rachel Schiff; Suleiman A Massarweh; Jiang Shou; Lavina Bharwani; Grazia Arpino; Mothaffar Rimawi; C Kent Osborne
Journal:  Cancer Chemother Pharmacol       Date:  2005-11       Impact factor: 3.333

2.  Old drugs, new tricks for triple-negative breast cancer.

Authors:  Lisa Carey
Journal:  Lancet Oncol       Date:  2015-03-18       Impact factor: 41.316

Review 3.  Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors.

Authors:  Christopher J Lord; Andrew N J Tutt; Alan Ashworth
Journal:  Annu Rev Med       Date:  2014-10-17       Impact factor: 13.739

4.  Estrogen receptors in hormone-dependent breast cancers.

Authors:  E V Jensen
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

5.  Central pathology laboratory review of HER2 and ER in early breast cancer: an ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study.

Authors:  Ann E McCullough; Patrizia Dell'orto; Monica M Reinholz; Richard D Gelber; Amylou C Dueck; Leila Russo; Robert B Jenkins; Stefania Andrighetto; Beiyun Chen; Christian Jackisch; Michael Untch; Edith A Perez; Martine J Piccart-Gebhart; Giuseppe Viale
Journal:  Breast Cancer Res Treat       Date:  2014-01-07       Impact factor: 4.872

Review 6.  Immunotherapy for the treatment of breast cancer.

Authors:  Brenda Ernst; Karen S Anderson
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

Review 7.  Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer.

Authors:  Gayathri Nagaraj; Cynthia Ma
Journal:  Breast Cancer Res Treat       Date:  2015-03-12       Impact factor: 4.872
  7 in total
  3 in total

1.  Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Authors:  Aurelia Vattai; Elif Akyol; Christina Kuhn; Simone Hofmann; Helene Heidegger; Franz von Koch; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Christine Spitzweg; Bettina Toth; Sven Mahner; Udo Jeschke; Nina Ditsch
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-13       Impact factor: 4.553

2.  Tumor biomarker conversion between primary and metastatic breast cancer: mRNA assessment and its concordance with immunohistochemistry.

Authors:  Stefan Stefanovic; Ralph Wirtz; Thomas M Deutsch; Andreas Hartkopf; Peter Sinn; Zsuzsanna Varga; Bettina Sobottka; Lakis Sotiris; Florin-Andrei Taran; Christoph Domschke; Andre Hennigs; Sara Y Brucker; Christof Sohn; Florian Schuetz; Andreas Schneeweiss; Markus Wallwiener
Journal:  Oncotarget       Date:  2017-05-19

3.  Prognostic Value of Molecular Breast Cancer Subtypes based on Her2, ESR1, PGR and Ki67 mRNA-Expression in Muscle Invasive Bladder Cancer.

Authors:  M C Kriegmair; R M Wirtz; T S Worst; J Breyer; M Ritter; B Keck; C Boehmer; W Otto; M Eckstein; C A Weis; A Hartmann; C Bolenz; P Erben
Journal:  Transl Oncol       Date:  2018-02-23       Impact factor: 4.243
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.